Homozygous WWOX deletions are indicative of poor prognosis (22) and alteration of 16q, which includes deletion of WWOX, were recognized by International Myeloma Working Groups as a recurrent secondary genetic event in high-risk MM (19, 20). This evidence concerns the gene WWOX and Miyoshi myopathy.